Results 101 to 110 of about 824 (158)

Identification and Characterization of Mitragynine or 7-Hydroxymitraynine Oral Dosage Form Products That Appeal to Children. [PDF]

J Pediatr Pharmacol Ther
White CM, Atallah M, Khoury DE.
europepmc   +1 more source

Cardio-pulmonary arrest in a patient revived with naloxone following reported use of 7-hydroxymitragynine

Clinical Toxicology
Mallory K. Pullman, Siva Rama Raju Kanumuri, Juan Francisco Leon, Stephen J. Cutler, Christopher R. McCurdy, Abhisheak Sharma   +5 more
openaire   +2 more sources

Nonswallowed Kratom-Derived Products: Unlawful Dietary Supplements That Endanger Public Health. [PDF]

Public Health Rep
White CM, Sedensky A, Belcourt J, Kulkarni P.   +3 more
europepmc   +1 more source

WHO Expert Committee on Drug Dependence: forty-fourth report. [PDF]

, 2022

core  

Mixtures Biotransformation: Multilayer Molecular Networking of Kratom Liver Metabolites. [PDF]

J Nat Prod
Crandall WJ, Weinberg J, Liu K, Lee CM, Singer G, Morgan ET, Jones DP, Quave CL.   +7 more
europepmc   +1 more source

Indole Alkaloids as Biased Opioid Receptor Modulators. [PDF]

Pharmaceuticals (Basel)
Grundmann O, Henderson A.
europepmc   +1 more source

Severe Early-Onset Withdrawal Following Intentional Use of Mitragynine Pseudoindoxyl: A Case Report and Emerging Clinical Considerations. [PDF]

Cureus
Stanciu CN.
europepmc   +1 more source

The Unregulated Rise of Kratom Drinks: Emerging Challenges and Policy Recommendations. [PDF]

Public Health Rep
Perry T, Chin S.
europepmc   +1 more source

In Vitro Pharmacology of Mitragynine at α-Adrenoceptors. [PDF]

ACS Chem Neurosci
Chen Y, Seto J, Obeng S, Mottinelli M, Mukhopadhyay S, Tyagi R, Hampson AJ, McCurdy CR, McMahon LR, Moniri NH, Canal CE.   +10 more
europepmc   +1 more source

Semi-synthesis in the exploration of opioid-targeting natural products. [PDF]

Nat Prod Rep
Riley AP.
europepmc   +1 more source